Clinical Trials Directory

Trials / Completed

CompletedNCT01303289

Clinical Evaluation of a Normoproteic Diet

Clinical Evaluation of a Normoproteic Diet With Ultra High Temperature Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Vegenat, S.A. · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The main objective of this trial is the clinical evaluation of a normoproteic diet, when this diet is used for total enteral nutrition in geriatric people. For 3 months,all the participants in the study will receive only tube feeding: The experimental group will receive the commercial preparation to evaluate (T-Diet Plus ®, Vegenat SA) and the control group will receive a standard diet (Jevity ®, Abbott Laboratories).

Detailed description

The project includes: * Product tolerance study: gastrointestinal and metabolic complications related to the product administration. * The monitoring of the intervention, and clinical and nutritional evaluation of the participants, including anthropometry, quality of life related to the health and clinical and nutritional status analytical evaluation (hematology and biochemistry). * The determination of the major biochemical variables related to the lipid profile and assessment of the antioxidant defense system, and also certain markers of metabolic syndrome and associated cardiovascular risk.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTT-Diet plus StandardT-Diet plus Standard is a complete balanced protein and energy oral nutrition supplement, indicated for the dietary management of patients with related malnutrition.
DIETARY_SUPPLEMENTJevityJEVITY is a diet for tube-fed patients in the medium to long term, to varying degrees of malnutrition with gastrointestinal disorders.

Timeline

Start date
2006-02-01
Primary completion
2007-01-01
Completion
2007-12-01
First posted
2011-02-24
Last updated
2011-02-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01303289. Inclusion in this directory is not an endorsement.